ATE323721T1 - CHOLINE-BINDING PROTEIN USED AS AN PNEUMOCOCCAL VACCINE - Google Patents
CHOLINE-BINDING PROTEIN USED AS AN PNEUMOCOCCAL VACCINEInfo
- Publication number
- ATE323721T1 ATE323721T1 AT97922539T AT97922539T ATE323721T1 AT E323721 T1 ATE323721 T1 AT E323721T1 AT 97922539 T AT97922539 T AT 97922539T AT 97922539 T AT97922539 T AT 97922539T AT E323721 T1 ATE323721 T1 AT E323721T1
- Authority
- AT
- Austria
- Prior art keywords
- choline binding
- bacterial
- binding protein
- binding proteins
- choline
- Prior art date
Links
- 101710164918 Choline-binding protein Proteins 0.000 title abstract 4
- 229940124733 pneumococcal vaccine Drugs 0.000 title 1
- 230000001580 bacterial effect Effects 0.000 abstract 6
- 108091016312 choline binding proteins Proteins 0.000 abstract 6
- 241000894006 Bacteria Species 0.000 abstract 1
- 102000016359 Fibronectins Human genes 0.000 abstract 1
- 108010067306 Fibronectins Proteins 0.000 abstract 1
- 241000192125 Firmicutes Species 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 102000012288 Phosphopyruvate Hydratase Human genes 0.000 abstract 1
- 108010022181 Phosphopyruvate Hydratase Proteins 0.000 abstract 1
- 241000194017 Streptococcus Species 0.000 abstract 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 abstract 1
- 229960001231 choline Drugs 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 150000003384 small molecules Chemical class 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
The invention relates to bacterial choline binding proteins (CBPs) which bind choline. Such proteins are particularly desirable for vaccines against appropriate strains of Gram positive bacteria, particularly streptococcus, and more particularly pneumococcus. Also provided are DNA sequences encoding the bacterial choline binding proteins or fragment thereof, antibodies to the bacterial choline binding proteins, pharmaceutical compositions comprising the bacterial choline binding proteins, antibodies to the bacterial choline binding proteins suitable for use in passive immunization, and small molecule inhibitors of choline binding protein mediated adhesion. Methods for diagnosing the presence of the bacterial choline binding protein, or of the bacteria, are also provided. In a specific embodiment, a streptococcal choline binding protein is an enolase, which demonstrates strong affinity for fibronectin.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64225096A | 1996-05-01 | 1996-05-01 | |
US1663296P | 1996-05-01 | 1996-05-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE323721T1 true ATE323721T1 (en) | 2006-05-15 |
Family
ID=26688869
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT97922539T ATE323721T1 (en) | 1996-05-01 | 1997-05-01 | CHOLINE-BINDING PROTEIN USED AS AN PNEUMOCOCCAL VACCINE |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0912608B1 (en) |
JP (1) | JP2000511411A (en) |
AT (1) | ATE323721T1 (en) |
AU (1) | AU732520B2 (en) |
CA (1) | CA2253252A1 (en) |
DE (1) | DE69735715T2 (en) |
ES (1) | ES2262177T3 (en) |
WO (1) | WO1997041151A2 (en) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7078042B2 (en) | 1995-09-15 | 2006-07-18 | Uab Research Foundation | Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor |
US6245335B1 (en) | 1996-05-01 | 2001-06-12 | The Rockefeller University | Choline binding proteins for anti-pneumococcal vaccines |
CA2269636A1 (en) * | 1996-11-12 | 1998-05-22 | The Regents Of The University Of Minnesota | C3 binding protein of streptococcus pneumoniae |
DE19708537A1 (en) * | 1997-03-03 | 1998-09-10 | Biotechnolog Forschung Gmbh | New surface protein (SpsA protein) from Streptococcus pneumoniae etc. |
US6676943B1 (en) | 1997-04-24 | 2004-01-13 | Regents Of The University Of Minnesota | Human complement C3-degrading protein from Streptococcus pneumoniae |
AU2004200125B2 (en) * | 1998-04-07 | 2006-07-27 | Med Immune, Inc. | Derivatives of Pneumococcal Choline Binding Proteins for Vaccines |
BR9909483A (en) * | 1998-04-07 | 2001-10-09 | Medimmune Inc | Choline pneumococcal binding protein derivatives for vaccines |
US6858706B2 (en) | 1998-04-07 | 2005-02-22 | St. Jude Children's Research Hospital | Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof |
PL193132B1 (en) * | 1998-04-07 | 2007-01-31 | Medimmune | A polypeptide comprising the amino acid of an n−terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof |
US6495139B2 (en) | 1998-11-19 | 2002-12-17 | St. Jude Children's Research Hospital | Identification and characterization of novel pneumococcal choline binding protein, CBPG, and diagnostic and therapeutic uses thereof |
AU2027400A (en) * | 1998-11-19 | 2000-06-05 | St. Jude Children's Research Hospital | Identification and characterization of novel pneumococcal choline binding proteins, cbpg and cbpd, and diagnostic and therapeutic uses thereof |
ATE422899T1 (en) | 1998-12-21 | 2009-03-15 | Medimmune Inc | STREPTOCOCCUS PNEUMONIAE PROTEINS AND IMMUNOGENIC FRAGMENTS FOR VACCINES |
WO2000056360A2 (en) | 1999-03-19 | 2000-09-28 | Smithkline Beecham Biologicals S.A. | Vaccine against antigens from bacteriae |
GB9918319D0 (en) | 1999-08-03 | 1999-10-06 | Smithkline Beecham Biolog | Vaccine composition |
GB0022742D0 (en) | 2000-09-15 | 2000-11-01 | Smithkline Beecham Biolog | Vaccine |
EP1961427A3 (en) | 2002-08-02 | 2009-11-04 | GlaxoSmithKline Biologicals S.A. | Neisserial vaccine compositions comprising a combination of antigens |
US7927858B2 (en) | 2002-11-01 | 2011-04-19 | Glaxosmithkline Biologicals, S.A. | Drying process |
ES2346314T3 (en) | 2003-10-02 | 2010-10-14 | Glaxosmithkline Biolog Sa | ANTIGENS OF B. PERTUSSIS AND USE OF THE SAME IN VACCINATION. |
GB0505996D0 (en) | 2005-03-23 | 2005-04-27 | Glaxosmithkline Biolog Sa | Fermentation process |
TWI457133B (en) | 2005-12-13 | 2014-10-21 | Glaxosmithkline Biolog Sa | Novel composition |
GB0607088D0 (en) | 2006-04-07 | 2006-05-17 | Glaxosmithkline Biolog Sa | Vaccine |
EP3020411A1 (en) | 2005-12-22 | 2016-05-18 | GlaxoSmithKline Biologicals s.a. | Vaccine |
EA015561B1 (en) | 2006-01-17 | 2011-08-30 | Арне Форсгрен | A NOVEL SURFACE EXPOSED HAEMOPHILUS INFLUENZAE PROTEIN (PROTEIN E; pE) |
WO2009000825A2 (en) | 2007-06-26 | 2008-12-31 | Glaxosmithkline Biologicals S.A. | Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates |
EA201001479A1 (en) | 2008-04-16 | 2011-06-30 | Глаксосмитклайн Байолоджикалс С.А. | VACCINE |
WO2010126146A1 (en) * | 2009-04-30 | 2010-11-04 | Tanaka Noriaki | Method or apparatus for determination of severity of renal diseases and method for operation of the apparatus |
GB201003924D0 (en) | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Immunogenic composition |
CN102869378A (en) | 2010-03-10 | 2013-01-09 | 葛兰素史密丝克莱恩生物有限公司 | Immunogenic composition |
GB201015132D0 (en) | 2010-09-10 | 2010-10-27 | Univ Bristol | Vaccine composition |
WO2012156391A1 (en) | 2011-05-17 | 2012-11-22 | Glaxosmithkline Biologicals S.A. | Vaccine against streptococcus pneumoniae |
US11207396B2 (en) | 2013-05-17 | 2021-12-28 | The Board Of Regents Of The University Of Texas System | Immunization to protect against adverse cardiac events relating to pneumococcal infection |
GB201518684D0 (en) | 2015-10-21 | 2015-12-02 | Glaxosmithkline Biolog Sa | Vaccine |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993024000A1 (en) * | 1992-05-29 | 1993-12-09 | Janet Yother | Methods for obtaining and purifying cell-free pneumococcal surface proteins from s. pneumoniae and use thereof |
CA2116261A1 (en) * | 1993-04-20 | 1994-10-21 | David E. Briles | Epitopic regions of pneumococcal surface protein a |
CN1192241A (en) * | 1995-06-07 | 1998-09-02 | 生化疫苗公司 | Streptococcal heat shock proteins members of the HSP70 family |
-
1997
- 1997-05-01 AT AT97922539T patent/ATE323721T1/en not_active IP Right Cessation
- 1997-05-01 DE DE69735715T patent/DE69735715T2/en not_active Expired - Lifetime
- 1997-05-01 AU AU28182/97A patent/AU732520B2/en not_active Ceased
- 1997-05-01 WO PCT/US1997/007198 patent/WO1997041151A2/en active IP Right Grant
- 1997-05-01 ES ES97922539T patent/ES2262177T3/en not_active Expired - Lifetime
- 1997-05-01 CA CA002253252A patent/CA2253252A1/en not_active Abandoned
- 1997-05-01 JP JP09539170A patent/JP2000511411A/en active Pending
- 1997-05-01 EP EP97922539A patent/EP0912608B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU2818297A (en) | 1997-11-19 |
CA2253252A1 (en) | 1997-11-06 |
WO1997041151A2 (en) | 1997-11-06 |
EP0912608A2 (en) | 1999-05-06 |
ES2262177T3 (en) | 2006-11-16 |
DE69735715T2 (en) | 2007-03-29 |
DE69735715D1 (en) | 2006-05-24 |
AU732520B2 (en) | 2001-04-26 |
EP0912608B1 (en) | 2006-04-19 |
JP2000511411A (en) | 2000-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69735715D1 (en) | Choline-binding protein used as a pneumococcal vaccine | |
WO1998018930A3 (en) | Streptococcus pneumoniae antigens and vaccines | |
NO20004161L (en) | Group B streptococcus antigens | |
WO2000039299A3 (en) | Streptococcus antigens | |
WO2001098334A3 (en) | Streptococcus antigens | |
HUP0004639A2 (en) | Chlamydia protein, gene sequence and uses thereof | |
NZ524888A (en) | Nucleic acids and proteins from streptococcus groups A & B | |
WO2002083855A3 (en) | Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof | |
WO2001031019A3 (en) | Neisserial antigenic peptides | |
CA2438080A1 (en) | Gonococcal proteins and nucleic acids | |
WO2000006737A8 (en) | Streptococcus pneumoniae proteins and nucleic acid molecules | |
ATE83801T1 (en) | METHODS AND MEANS FOR PRODUCING A PROTEIN WITH THE SAME IGG SPECIFICITY AS PROTEIN G. | |
BR0208874A (en) | Surface proteins of streptococcus pyogenes | |
WO2000076540A3 (en) | Streptococcus pneumoniae proteins and vaccines | |
ATE522541T1 (en) | BACTERIAL ADHESIN CONFORMERS | |
RU2010107878A (en) | IMMUNOGENIC PROTEINS STREPTOCOCCUS | |
ATE240351T1 (en) | RIB PROTEIN, A SURFACE PROTEIN WHICH CONFERS IMMUNITY AGAINST MANY GROUP B STREPTOCOCCUS STRAINS, RIB PROTEIN PURIFICATION METHOD, TEST KIT AND PHARMACEUTICAL COMPOSITION (MEDICINE) | |
SE9602496D0 (en) | Method and means for producing a fibrinogen binding protein and its use in biotechnology | |
WO2001081380A3 (en) | Immunogenic pneumococcal protein and vaccine compositions thereof | |
WO2001096379A3 (en) | Immunization of dairy cattle with chimeric gapc protein against streptococcus infection | |
BR9908476A (en) | Peptide, therapeutic composition, and, process to confer protective immunity to a patient, against s infection. pneumoniae | |
AU1540795A (en) | Diagnosis and treatment of infections due to streptococci and enterococci | |
AU2667600A (en) | Identification of specific differentially expressed antigens | |
SE9402490D0 (en) | Vitronection binding protein | |
SE9804491D0 (en) | Novel fibronectin binding protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |